LOS ANGELES, Calif., February 11, 2025 — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics...
Vous n'êtes pas connecté
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism spectrum disorder.
LOS ANGELES, Calif., February 11, 2025 — Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics...
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms,...
WEDNESDAY, Feb. 12, 2025 -- Too often, ADHD and autism coincide in children. New research finds that for many of those kids, this dual diagnosis...
A new international study has found that a simple tablet treatment could improve survival rates for people with chronic lymphocytic leukemia (CLL), a...
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children,...
A new study from the University of California, San Diego has found that a common class of drugs may increase the risk of cognitive decline,...
A new study reveals that patients with long Covid and chronic fatigue syndrome (CFS) show swelling in the hippocampus, a brain region crucial for...
Popular diabetes and weight-loss drug Ozempic is being tested for several additional health issues, such as drinking disorders and sleep apnea.
Autism Spectrum Disorder (ASD) is a complex developmental condition characterised by challenges in social communication, restricted interests, and...
MONDAY, Feb. 10, 2025 — Learning a second language may seem like an unusual approach to treating autism, but research points to surprising...